Abuse of Amphetamines and Structural Abnormalities in the Brain
暂无分享,去创建一个
George Bartzokis | Steven Berman | G. Bartzokis | J. O’Neill | E. London | S. Fears | S. Berman | Scott Fears | Joseph O'Neill | Edythe D. London
[1] Nick C. Fox,et al. Ten simple rules for reporting voxel-based morphometry studies , 2008, NeuroImage.
[2] Stephen Taylor,et al. Volume increases in striatum associated with positive symptom reduction in schizophrenia: A preliminary observation , 2005, Psychiatry Research: Neuroimaging.
[3] Alan C. Evans,et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.
[4] J. Monterosso,et al. Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse , 2008, Molecular Psychiatry.
[5] B. Yamamoto,et al. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. , 2007, Addiction.
[6] D. Wong,et al. Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size. , 1993, The American journal of psychiatry.
[7] Martha Elizabeth Shenton,et al. Voxel-Based Morphometric Analysis of Gray Matter in First Episode Schizophrenia , 2002, NeuroImage.
[8] S. F. Witelson. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. , 1989, Brain : a journal of neurology.
[9] Karl J. Friston,et al. Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.
[10] G. C. Wagner,et al. Methamphetamine-induced neuronal damage: A possible role for free radicals , 1989, Neuropharmacology.
[11] M. Leider. Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .
[12] Liesbeth Reneman,et al. A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users , 2007, Neuropsychopharmacology.
[13] H. Cann,et al. Use of d-amphetamine and related central nervous system stimulants in children. , 1973, Pediatrics.
[14] J. Polich,et al. Neuropsychology and neuropharmacology of P3a and P3b. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[15] Robert Miller,et al. Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 1: Pathophysiology and Mechanisms of Induction , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[16] Jim Mintz,et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.
[17] Shu-Wei Sun,et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.
[18] L S Seiden,et al. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996, NIDA research monograph.
[19] K. Frey,et al. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.
[20] Karl J. Friston,et al. Distributional Assumptions in Voxel-Based Morphometry , 2002, NeuroImage.
[21] N. Volkow,et al. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. , 2004, The American journal of psychiatry.
[22] L. Johnston,et al. Monitoring the Future national survey results on drug use, 1975-2017: Volume I, secondary school students , 2005 .
[23] J. Cadet,et al. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. , 1999, European journal of pharmacology.
[24] U. C. Wieshmann,et al. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy , 2004, NeuroImage.
[25] G. Gratton,et al. Combining structural and functional neuroimaging data for studying brain connectivity: a review. , 2008, Psychophysiology.
[26] Michael J. Schmidt,et al. 3H-amphetamine concentrations in the brains of young and aged rats: Implications for assessment of drug effects in aged animals , 1980, Neurobiology of Aging.
[27] G. Bartzokis,et al. Brain Volume: Age-Related Changes , 2009 .
[28] H. W. Clark,et al. Premorbid brain size is a determinant of functional reserve in abstinent crack-cocaine and crack-cocaine–alcohol-dependent adults , 1998, Journal of the International Neuropsychological Society.
[29] Christos Davatzikos,et al. Why voxel-based morphometric analysis should be used with great caution when characterizing group differences , 2004, NeuroImage.
[30] Christine Fennema-Notestine,et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. , 2005, The American journal of psychiatry.
[31] D. Segal,et al. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. , 1999, The Journal of pharmacology and experimental therapeutics.
[32] J. Swanson,et al. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.
[33] D. Segal,et al. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. , 1997, The Journal of pharmacology and experimental therapeutics.
[34] P. Renshaw,et al. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. , 2007, Drug and Alcohol Dependence.
[35] C. Advokat. Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD , 2007, Journal of attention disorders.
[36] Patrick M. O'Malley,et al. Monitoring the Future: National Survey Results on Drug Use, 1975-2006. Volume II: College Students & Adults Ages 19-25. NIH Publication No. 07-6206. , 2007 .
[37] George Bartzokis,et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research , 2000, Psychiatry Research: Neuroimaging.
[38] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. , 1986, Stroke.
[39] R. Gainetdinov,et al. Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice , 1999, The Journal of Neuroscience.
[40] R. Danielsson,et al. Brain lipid composition in postnatal iron‐induced motor behavior alterations following chronic neuroleptic administration in mice , 2006, The FEBS journal.
[41] A. Levey,et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.
[42] P. Renshaw,et al. Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. , 2006, Drug and alcohol dependence.
[43] Jim Mintz,et al. Brain maturation may be arrested in chronic cocaine addicts , 2002, Biological Psychiatry.
[44] Karl J. Friston,et al. Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias , 2002, NeuroImage.
[45] T. Robinson,et al. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. , 1997, European journal of pharmacology.
[46] F. Wan,et al. Nomifensine attenuates d-amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats. , 2000, The Chinese journal of physiology.
[47] N. Volkow,et al. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. , 2007, Addiction.
[48] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.
[49] N. A. Thacker,et al. Tutorial: A Critical Analysis of Voxel Based Morphometry (VBM). , 2003 .
[50] Graeme D. Jackson,et al. Composite voxel-based analysis of volume and T2 relaxometry in temporal lobe epilepsy , 2008, NeuroImage.
[51] J. O'Callaghan,et al. Age as a Susceptibility Factor in the Striatal Dopaminergic Neurotoxicity Observed in the Mouse following Substituted Amphetamine Exposure , 2000, Annals of the New York Academy of Sciences.
[52] T. Robbins,et al. Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers: Evidence for Monoaminergic Mechanisms , 1999, Neuropsychopharmacology.
[53] C. Kassed,et al. Brain injury: prolonged induction of transcription factors. , 2000, Acta neurobiologiae experimentalis.
[54] K. Johnson-Davis,et al. Age-Dependent Methamphetamine-Induced Alterations in Vesicular Monoamine Transporter-2 Function: Implications for Neurotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.
[55] Linda Chang,et al. Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response , 2005, Biological Psychiatry.
[56] G. Bartzokis,et al. The incidence of T2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific. , 1999, AJNR. American journal of neuroradiology.
[57] E. Check. Psychedelic drugs: The ups and downs of ecstasy , 2004, Nature.
[58] K. Frey,et al. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. , 1996, Nuclear medicine and biology.
[59] Nora D. Volkow,et al. Modifications radiologiques et neurologiques chez les toxicomanes: étude par résonance magnétique , 1988 .
[60] W. Melega,et al. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss , 2000, Brain Research.
[61] R. Doblin. A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA , 2002, Journal of psychoactive drugs.
[62] Michael A Downes,et al. Amphetamine‐induced movement disorder , 2005, Emergency medicine Australasia : EMA.
[63] U. McCann,et al. Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates , 2005, Journal of Pharmacology and Experimental Therapeutics.
[64] P. Renshaw,et al. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. , 2003, Drug and alcohol dependence.
[65] N. Volkow,et al. Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.
[66] In Chan Song,et al. Shape changes of the corpus callosum in abstinent methamphetamine users , 2005, Neuroscience Letters.
[67] E. Bender. FDA Approves Study of Ecstasy In Some Terminally Ill Patients , 2005 .
[68] In Chan Song,et al. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. , 2007, The international journal of neuropsychopharmacology.
[69] P. Riederer,et al. The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration , 2003, Experimental Neurology.
[70] Linda Chang,et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users , 2002, Psychiatry Research: Neuroimaging.
[71] Fred L. Bookstein,et al. “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.
[72] Bennett A. Landman,et al. Statistical parametric mapping of brain morphology: Sensitivity is dramatically increased by using brain-extracted images as inputs , 2006, NeuroImage.
[73] Dennis C Harvey,et al. Methamphetamine increases basal ganglia iron to levels observed in aging , 2007, Neuroreport.
[74] NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. , 2005, NTP CERHR MON.
[75] G. C. Wagner,et al. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. , 2003, Journal of pharmacological sciences.
[76] J. Dunnick,et al. Decreases in spontaneous tumors in rats and mice after treatment with amphetamine. , 1991, Toxicology.
[77] Richard S. J. Frackowiak,et al. Navigation-related structural change in the hippocampi of taxi drivers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[78] Seiden Ls,et al. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996 .
[79] C. Harper,et al. Ethanol and brain damage. , 2005, Current opinion in pharmacology.
[80] Walter Ling,et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. , 2004, Archives of general psychiatry.
[81] G. Bartzokis. BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. , 2005, Adolescent psychiatry.
[82] David Araújo,et al. Correlation between voxel based morphometry and manual volumetry in magnetic resonance images of the human brain. , 2008, Anais da Academia Brasileira de Ciencias.
[83] G. Teuchert-Noodt,et al. Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methamphetamine , 1991, Neuropharmacology.
[84] M. Bannon,et al. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin , 2004, Journal of neurochemistry.
[85] Patrick M. O'Malley,et al. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .
[86] T. Beveridge,et al. Psychostimulants and monoamine transporters: upsetting the balance. , 2005, Current opinion in pharmacology.
[87] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[88] A. Morton,et al. Methamphetamine toxicity in mice is potentiated by exposure to loud music , 2001, Neuroreport.
[89] S. Lawrie,et al. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia , 2003, Schizophrenia Research.
[90] Andreas Meyer-Lindenberg,et al. False positives in imaging genetics , 2008, NeuroImage.
[91] Christian Beaulieu,et al. Voxel based versus region of interest analysis in diffusion tensor imaging of neurodevelopment , 2007, NeuroImage.
[92] P. Renshaw,et al. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. , 2005, The international journal of neuropsychopharmacology.
[93] Michael H. Baumann,et al. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings , 2006, Psychopharmacology.
[94] P. Renshaw,et al. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects , 2004, Psychiatry Research: Neuroimaging.
[95] Sushil K. Sharma,et al. Attenuation of Cocaine and Methamphetamine Neurotoxicity by Coenzyme Q10 , 2006, Neurochemical Research.
[96] G. Pearlson,et al. Decreased frontal white-matter volume in chronic substance abuse. , 2005, The international journal of neuropsychopharmacology.
[97] P. Thompson,et al. Relationship among neuroimaging indices of cerebral health during normal aging , 2008, Human brain mapping.
[98] C. Chi,et al. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. , 2006, Toxicology.
[99] S. Kish,et al. Why is parkinsonism not a feature of human methamphetamine users? , 2004, Brain : a journal of neurology.
[100] J. Krystal,et al. Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.
[101] Paul M. Thompson,et al. Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine , 2004, The Journal of Neuroscience.
[102] Jonathan D. Cohen,et al. Decision making, the P3, and the locus coeruleus-norepinephrine system. , 2005, Psychological bulletin.
[103] Neil Roberts,et al. Voxel-Based Morphometric Comparison of Hippocampal and Extrahippocampal Abnormalities in Patients with Left and Right Hippocampal Atrophy , 2002, NeuroImage.
[104] H. Sumnall,et al. Altered states: the clinical effects of Ecstasy. , 2003, Pharmacology & therapeutics.
[105] Rodney J. Croft,et al. The relative contributions of ecstasy and cannabis to cognitive impairment , 2001, Psychopharmacology.
[106] P. Sonsalla,et al. Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment , 2000, Journal of neurochemistry.
[107] A. Levey,et al. Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.
[108] C. Achat-Mendes,et al. Impairment in Consolidation of Learned Place Preference Following Dopaminergic Neurotoxicity in Mice is Ameliorated by N-acetylcysteine but not D1 and D2 Dopamine Receptor Agonists , 2007, Neuropsychopharmacology.
[109] G. Bartzokis,et al. Tardive dyskinesia and serum iron indices , 1998, Biological Psychiatry.
[110] J. Rapoport,et al. Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[111] P. Renshaw,et al. Increased white matter hyperintensities in male methamphetamine abusers. , 2006, Drug and alcohol dependence.
[112] N. Volkow,et al. Radiological and neurological changes in the drug abuse patient: a study with MRI. , 1988, Journal of neuroradiology. Journal de neuroradiologie.
[113] D. Pubill,et al. Methyllycaconitine Prevents Methamphetamine-Induced Effects in Mouse Striatum: Involvement of α7 Nicotinic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.
[114] Khader M Hasan,et al. Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making , 2007, The American journal of drug and alcohol abuse.
[115] B. Madras,et al. The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.
[116] Robert Turner,et al. Voxel-based cortical thickness measurements in MRI , 2008, NeuroImage.
[117] E. Jodo,et al. Effects of repeated administration of methamphetamine on P3-like potentials in rats. , 1999, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[118] W. Slikker,et al. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats , 1993, Pharmacology Biochemistry and Behavior.
[119] U. McCann,et al. Methylphenidate and brain dopamine neurotoxicity , 1997, Brain Research.
[120] P. Phansuwan-Pujito,et al. Melatonin protects SK‐N‐SH neuroblastoma cells from amphetamine‐induced neurotoxicity , 2007, Journal of pineal research.
[121] G. Bartzokis,et al. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.
[122] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[123] F. Benes,et al. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. , 1994, Archives of general psychiatry.
[124] S. Haber,et al. Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting , 2000, The Journal of Neuroscience.
[125] R. Rawson,et al. Why do we need an Addiction supplement focused on methamphetamine? , 2007, Addiction.
[126] Eve C. Johnstone,et al. Structural Gray Matter Differences between First-Episode Schizophrenics and Normal Controls Using Voxel-Based Morphometry , 2002, NeuroImage.
[127] Linda Chang,et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure , 2004, Psychiatry Research: Neuroimaging.
[128] J S Fowler,et al. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. , 2001, The American journal of psychiatry.
[129] E. Gouzoulis-Mayfrank,et al. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? , 2006, Addiction.
[130] Ganesan Venkatasubramanian,et al. IMAGING STUDY: Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence , 2007, Addiction biology.
[131] C. Abraham,et al. Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review , 2008, Addiction.
[132] C. Hanstock,et al. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients , 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.